Retinoic acid induced 2 (RAI2) methylation serves as an independent poor prognostic marker in CRC by inhibiting the protein kinase B (AKT) signaling pathway and suppressing CRC cell growth in vitro and in vivo [128]. The gene discussed is AKT1; the disease is colorectal carcinoma.